Mobocertinib for Named Patient Import

Mobocertinib for Indian Patients

Mobocertinib is a relatively new medication available in the international markets. It is usedin the clinical management of non-small cell lung cancer. It is a product of Takeda Pharmaceutical Company, a global major with huge experience of developing innovative drugs for rare diseases. Mobocertinib is known as Exkivity, its registered brand name. Available in the European and US markets, experts all around the world are weighing in on its core benefits for the lung cancer patients.

Mobocertinib or Exkivity in India is not actively promoted by the innovator. Exkivity 40mg capsules in India will be formally available once the company secures the regional registration. But, patients need not wait for their official introduction if they are advised for the medicine. Exkivity (Mobocertinib) price in India can be worked out based on the global trends. Legal sourcing or procurement is very much possible through Named Patient Import provisions.

Mobocertinib in India? Seek expert assistance

Our services are available for patients who need professional assistance regarding the sourcing and completing the mandatory documentation. While the patients and their caregivers are free to contact the global suppliers and order the medicines, they may still need help and assistance when it comes to validating the sources. It may be a better idea to work with suppliers who have the known capabilities of servicing the Indian patients. We will guide you in every way possible when it comes to Mobocertinib India sourcing.

You can write to us or call us - nhs@noelbiotech.com; + 91 9677010046 / + 91 9929277766.